source: An Inside Look at China’s Regulatory and Drug Approval Processes - Redica Systems
don’t forget we are still looking at a US IND for P2
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial, page-149
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.005(0.42%) |
Mkt cap ! $207.6M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.17 | $105.9K | 89.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12349 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 1644 | 1 |
View Market Depth
| Last trade - 14.21pm 07/08/2025 (20 minute delay) ? |
| RAC (ASX) Chart |